Antidiabetics Market - Top Companies and Manufacturers

  • Report ID: 6405
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Antidiabetics Landscape

    Key players in the antidiabetics market are employing several organic and inorganic strategies such as new product launches, collaborations, partnerships, mergers, and regional expansion to increase their market reach and profit shares. Industry giants are entering into partnership strategies with other players to boost technological innovations and develop advanced solutions.

    Some of the key players include

    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boehringer Ingelheim
    • Bristol-Myers Squibb Company
    • Pfizer, Inc.
    • Halozyme Therapeutics
    • AstraZeneca Plc
    • Bayer AG
    • Johnson & Johnson Services Inc.
    • Sanofi S.A.
    • Oramed Pharmaceuticals
    • Novo Nordisk
    • Merck & Co. Inc
    • Novartis AG

Browse Key Market Insights with Data Illustration:

In the News

  • In January 2024, Glenmark Pharmaceuticals Ltd. announced the launch of the anti‐diabetic biosimilar Lirafit. Lirafit aids in controlling glycemic in adult patients with type 2 diabetes mellitus
  • In October 2022, NuGen Medical Devices Inc. revealed the launch of its InsuJet device in Canada. InsuJet is a high-quality needle-free drug delivery device used by diabetic patients to take insulin.

Author Credits:  Radhika Pawar


  • Report ID: 6405
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global antidiabetics market is estimated at USD 116.3 billion in 2025.

Expanding at a CAGR of 8.8%, the global market is expected to increase from USD 106.9 billion in 2024 to USD 294.1 billion by 2037.

Some of the leading companies are Eli Lilly and Company, Pfizer, Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., and Novartis AG.

Insulin is anticipated to capture 53.5% of the global market share by 2037 and lead the segment growth throughout the forecast period.

North America leads the global sales of antidiabetics owing to the strong presence of key market players and diabetes research and treatment organizations.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample